Medicine

Flexion`s knee pain drug gets FDA nod, shares hit life high

Flexion`s knee pain drug gets FDA nod, shares hit life high

Published 06/10/2017

Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday. [more…]

Cash injection: sovereign funds target healthcare

Cash injection: sovereign funds target healthcare

Published 06/10/2017

Imagine contact lenses that monitor glucose levels for diabetics, tiny implants to tackle chronic diseases, or algorithms that crunch data to predict illness rates. [more…]

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

Published 05/10/2017

A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement. [more…]

New Jersey sues Insys as opioid maker settles with Massachusetts

New Jersey sues Insys as opioid maker settles with Massachusetts

Published 05/10/2017

New Jersey on Thursday accused Insys Therapeutics Inc of engaging in a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations. [more…]

Eli Lilly defeats challenge to Alimta cancer drug patent

Eli Lilly defeats challenge to Alimta cancer drug patent

Published 05/10/2017

A federal patent review board on Thursday rejected a challenge to a patent covering Eli Lilly and Co's Alimta drug to treat some lung cancers and mesothelioma. [more…]

Lilly wins Alimta patent dispute in U.S.

Lilly wins Alimta patent dispute in U.S.

Published 05/10/2017

The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co in a patent dispute over its cancer drug Alimta with Neptune Generics LLC and Sandoz Inc. [more…]

Oxford team to test universal flu vaccine in world first

Oxford team to test universal flu vaccine in world first

Published 03/10/2017

A seasonal flu vaccine that would be the first in the world to fight all types of the virus is to be tested in a two-year clinical trial involving more than 2,000 patients by researchers in Oxford. [more…]

Switching to e-cigarettes could save 6.6 million American smokers: researchers

Switching to e-cigarettes could save 6.6 million American smokers: researchers

Published 02/10/2017

Up to 6.6 million early deaths in America might be averted over 10 years if smokers switched to e-cigarettes, and the nicotine delivery devices should be adopted as part of an "endgame for cigarette smoking", researchers said on Monday. [more…]

FDA aims to speed up arrival of complex generic drugs

FDA aims to speed up arrival of complex generic drugs

Published 02/10/2017

The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV's emergency EpiPen in an effort to address the rising cost of pharmaceuticals. [more…]

Americans want required food labels even if they don`t read them

Americans want required food labels even if they don`t read them

Published 02/10/2017

A majority of Americans want the U.S. government to require nutrition labels on food packaging, including people who do not read them, according to a Reuters/Ipsos opinion poll released as the Trump administration delays tougher new requirements. [more…]